Treatment of cerebral infarction includes ultra-early thrombolytic therapy, acute phase improvement of blood circulation, neuroprotection and anti-platelet aggregation therapy. In case of cerebral embolism, anticoagulation and fibrin-lowering therapy can be given. If the patient has heavy somatic neurological symptoms, butylphthalide therapy can be given to improve the signs and symptoms of neurological deficits, and rehabilitation therapy can be given as early as possible after the patient’s condition is stabilized. If the patient has a cerebral watershed infarction, volume expansion therapy may be given if the blood pressure is low. If the patient has increased intracranial pressure, cranial pressure-lowering therapy can be given. If there is impaired consciousness, brain waking treatment should be given. For patients with cerebral hemorrhage, if there are indications, try to give surgical treatment. If there is no indication for surgery, conservative treatment is usually given, including neuroprotection and cranial pressure-lowering therapy, and commonly used pressure-lowering drugs include mannitol, glycerol fructose and tachyphylaxis. If the patient has impaired consciousness, the patient should also be given brain-awakening treatment, and the commonly used brain-awakening drugs include brain-awakening sedative and compound musk.